SI-BONE (NASDAQ: SIBN) CEO sells shares to cover RSU taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
SI-BONE, Inc. director and Chief Executive Officer Laura Francis reported a mix of stock awards and sales. On February 16, 2026, she acquired a total of 229,481 shares of common stock through grants and restricted stock unit awards at a stated price of $0.00 per share, which will vest over three to four years based on time and total shareholder return performance conditions. On February 17, 2026, she sold 93,475 shares of common stock in a series of open-market transactions at weighted average prices around $15.30 per share to cover tax withholding obligations from vesting restricted stock units, as disclosed in a footnote. Following these sales, she directly owned 544,369 shares, including 414,439 shares issuable upon settlement of restricted stock units, and an additional 351,319 shares were held indirectly by The David & Laura Joint Rev Tr.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 93,475 shares ($1,432,122)
Net Sell
12 txns
Insider
FRANCIS LAURA
Role
Chief Executive Officer
Sold
93,475 shs ($1.43M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 15,569 | $15.3515 | $239K |
| Sale | Common Stock | 3,893 | $15.2866 | $60K |
| Sale | Common Stock | 18,889 | $15.3229 | $289K |
| Sale | Common Stock | 39,764 | $15.2919 | $608K |
| Sale | Common Stock | 3,203 | $15.3128 | $49K |
| Sale | Common Stock | 2,236 | $15.2949 | $34K |
| Sale | Common Stock | 7,888 | $15.4362 | $122K |
| Sale | Common Stock | 2,033 | $15.2951 | $31K |
| Grant/Award | Common Stock | 114,741 | $0.00 | -- |
| Grant/Award | Common Stock | 57,370 | $0.00 | -- |
| Grant/Award | Common Stock | 57,370 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 622,275 shares (Direct);
Common Stock — 351,319 shares (Indirect, by Trust)
Footnotes (1)
- Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on February 15, 2026, and will be released in quarterly installments, subject to the Reporting Person's continued service through each relevant vesting date. Shares held by The David & Laura Joint Rev Tr. Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $15.12 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This transaction was executed in multiple trades at prices ranging from $15.15 USD to $15.53 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This transaction was executed in multiple trades at prices ranging from $15.13 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This transaction was executed in multiple trades at prices ranging from $15.13 USD to $15.51 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This transaction was executed in multiple trades at prices ranging from $15.24 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes 414,439 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
